Pacira BioSciences, Inc. PCRX Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s common stock, par value (in dollars per share)?
- Pacira BioSciences, Inc. (PCRX) reported common stock, par value (in dollars per share) of $0 in Q1 2026.
- How has Pacira BioSciences, Inc.'s common stock, par value (in dollars per share) changed year-over-year?
- Pacira BioSciences, Inc.'s common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Pacira BioSciences, Inc.'s common stock, par value (in dollars per share)?
- Over 5 years (2020 to 2025), Pacira BioSciences, Inc.'s common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.